Professor Damien Gruson
Cliniques Saint-Luc UCL, Brussels (Belgium)
Membership:
FESC Member
HFA Member
Biography
Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He is the head of the department of Clinical Biochemistry of the Cliniques Universitaires Saint Luc. He is also member of the research unit on Endocrinology Diabetes and Nutrition of the Catholic University of Louvain. Pr. D. Gruson has published numerous articles in several international peer-reviewed journals. Pr. D. Gruson is Chair of the division on Emerging Technology of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Pr. D. Gruson is also Fellow of the European Society of Cardiology.
Contributor content
Presentation
Integrating point-of-care NT-proBNP testing into mobile health: enhancing diagnosis, screening, and monitoring of heart failure
Presentation
CA125 assessment using ABEI-based assay in heart failure: implications for disease severity and cardiac biomarkers
Presentation
Increase of CA125 in Heart Failure with reduced ejection fraction: association with cardiovascular mortality, Galectin-3 and Fibroblast Growth Factor-23
Presentation
The ratio of fibroblast growth factor 23 to phosphorus as a predictor of cardiovascular death in heart failure patients with reduced ejection fraction.
Presentation
Determinant factors of plasma fibroblast growth factor 23 levels in patients with heart failure patients with reduced ejection fraction
Presentation
Increase of high molecular weight adiponectin in heart failure patients with reduced ejection fraction.
Presentation
Incremental value of intact fibroblast Growth factor 23 to natriuretic peptides for long-term risk estimation of heart failure patientsg
Presentation
Assessment of intact fibroblast growth factor 23 in patients with heart failure with reduced ejection fraction
Presentation
Combining natriuretic peptides and 1, 25-dihydroxyvitamin D testing improves the predictive value for cardiovascular death in heart failure
Presentation
